Hazlett, Burt & Watson’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$795K Sell
8,655
-109
-1% -$9.54K 0.21% 116
2026
Q1
$747K Sell
8,764
-14
-0.2% -$1.25K 0.23% 104
2025
Q4
$693K Sell
8,778
-389
-4% -$30.5K 0.22% 100
2025
Q3
$733K Sell
9,167
-452
-5% -$38.6K 0.26% 91
2025
Q2
$874K Sell
9,619
-163
-2% -$14.9K 0.36% 67
2025
Q1
$915K Buy
9,782
+33
+0.3% +$2.96K 0.41% 60
2024
Q4
$887K Sell
9,749
-189
-2% -$18K 0.39% 63
2024
Q3
$1.03M Sell
9,938
-93
-0.9% -$9.48K 0.47% 47
2024
Q2
$976K Buy
10,031
+6,364
+174% +$587K 0.5% 44
2024
Q1
$330K Buy
3,667
+775
+27% +$65.7K 0.2% 108
2023
Q4
$232K Sell
2,892
-200
-6% -$15K 0.16% 138
2023
Q3
$220K Sell
3,092
-2,456
-44% -$184K 0.16% 134
2023
Q2
$428K Buy
5,548
+15
+0.3% +$1.16K 0.32% 63
2023
Q1
$417K Buy
5,533
+15
+0.3% +$1.11K 0.34% 61
2022
Q4
$435K Buy
5,518
+16
+0.3% +$1.2K 0.38% 50
2022
Q3
$386K Sell
5,502
-7
-0.1% -$549 0.37% 49
2022
Q2
$442K Buy
5,509
+14
+0.3% +$1.09K 0.41% 51
2022
Q1
$418K Buy
+5,495
New +$435K 0.33% 62

Other funds holding CL

Hazlett, Burt & Watson's CL Position: Q2 2026 in Review

Hazlett, Burt & Watson reduced its Colgate-Palmolive (CL) stake by 1.2% in Q2 2026, selling an estimated $9.54K and leaving 8,655 shares worth $795K. The position accounts for 0.21% of the portfolio, ranked #116.

Hazlett, Burt & Watson first reported a position in CL in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.03M in Q3 2024. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Hazlett, Burt & Watson held 8,655 shares of Colgate-Palmolive worth $795K as of Q2 2026.
  • Hazlett, Burt & Watson sold 109 Colgate-Palmolive shares in Q2 2026, an estimated $9.54K.
  • Colgate-Palmolive made up 0.21% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #116 holding.
  • Hazlett, Burt & Watson first reported a position in Colgate-Palmolive in Q1 2022 and has held it in 18 quarters since.
  • Hazlett, Burt & Watson's Colgate-Palmolive position peaked at $1.03M in Q3 2024.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.